arginine has been researched along with Coronary Restenosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HY; Chen, YY; Hau, WK; Hsueh, CH; Huang, WC; Lu, TM; Teng, HI; Tsai, CT; Wu, CJ | 1 |
| Adamo, RF; Alferiev, IS; Chorny, M; Fishbein, I; Forbes, SP; Levy, RJ | 1 |
| Aydinalp, A; Bal, UA; Kanyilmaz, S; Kaynar, G; Müderrisoğlu, IH; Murat, K; Yıldırır, A | 1 |
| Faldynova, L; Karpisek, M; Kovarova, P; Kukla, P; Kusnierova, P; Pleva, L; Plevova, P; Zapletalova, J | 1 |
| Hirohata, A; Kataoka, K; Kimura, T; Kozuma, K; Morino, Y; Tanabe, K; Tobaru, T; Yasuda, S | 1 |
| Ari, H; Ari, S; Bozat, T; Erdoğan, E; Huysal, K; Koca, V; Tiryakioğlu, O; Ustündağ, Y | 1 |
| Egashira, K; Fukumoto, Y; Kaku, T; Kubo, T; Shimokawa, H; Takeshita, A; Urabe, Y | 1 |
| Exner, M; Mannhalter, C; Minar, E; Mlekusch, W; Sabeti, S; Schillinger, M; Wagner, O | 1 |
| Butterworth, J; Cannon, MA; Hyland, JM; Riley, RD | 1 |
| Bartus, S; Dembinska-Kiec, A; Dubiel, JS; Dudek, D; Heba, G; Huk, I; Kaluza, GL; Legutko, J; Partyka, L | 1 |
| Deutsch, V; George, J; Herz, I; Izraelov, S; Keren, G; Miller, H; Roth, A; Shmuel, SB | 1 |
| Daikoku, S; Goto, Y; Itoh, A; Itoh, T; Miyazaki, S; Morii, I; Nonogi, H | 1 |
| Kajiyama, A; Oka, T; Saito, D; Shiraki, T; Takamura, T | 1 |
| Fujii, M; Hirahara, T; Ikeda, N; Kubo, N; Matsushima, K; Ohmura, N; Saito, M; Yasu, T | 1 |
| Cooke, JP; Fitzgerald, PJ; Hayase, M; Hibi, K; Hosokawa, H; Suzuki, T; Yeung, AC; Yock, PG; Yokoya, K | 1 |
| Anker, SD; Coats, AJ; Dietz, R; Francis, DP; Gläser, C; Greiser, P; Gross, M; Norwig, A; Rauchhaus, M; Schulz, S; Weidhase, L | 1 |
6 trial(s) available for arginine and Coronary Restenosis
| Article | Year |
|---|---|
Augmented vasodilator response to L-arginine after coronary angioplasty may attenuate restenosis.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Coronary Restenosis; Coronary Vessels; Humans; Nitric Oxide; Time Factors; Vasodilator Agents | 2002 |
L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study.
Topics: Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Humans; Hyperplasia; Male; Prospective Studies; Stents; Tunica Intima; Ultrasonography, Interventional | 2004 |
L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Anti-Idiotypic; Arginine; CD4-CD8 Ratio; Coronary Restenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Lymphocyte Activation; Male; Middle Aged; Nitric Oxide; Probability; Prognosis; Stents; Treatment Outcome | 2004 |
Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.
Topics: Aged; Angioplasty, Balloon; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Risk Factors; Sulfonamides; Time Factors | 2004 |
[Prospective randomized study of argatroban versus heparin anticoagulation therapy after percutaneous coronary intervention for acute myocardial infarction].
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Restenosis; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Prospective Studies; Sulfonamides | 2004 |
Effect of local delivery of L-arginine on in-stent restenosis in humans.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Prospective Studies; Stents; Ultrasonography, Interventional | 2002 |
10 other study(ies) available for arginine and Coronary Restenosis
| Article | Year |
|---|---|
Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
Topics: Aged; Arginine; Biomarkers; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prospective Studies; Prosthesis Failure; Risk Factors; Time Factors; Tomography, Optical Coherence | 2019 |
Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis.
Topics: Adenoviridae; Animals; Aorta; Arginine; Biopterins; Carotid Arteries; Cell Proliferation; Cell Survival; Coronary Restenosis; Cross-Linking Reagents; Disease Models, Animal; Genetic Therapy; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2013 |
Could plasma asymmetric dimethylarginine level be a novel predictor beyond the classic predictors of stent restenosis?
Topics: Arginine; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Restenosis; Cross-Sectional Studies; Female; Humans; Logistic Models; Male; Predictive Value of Tests | 2014 |
Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.
Topics: Aged; Apolipoproteins D; Apolipoproteins E; Arginine; Biomarkers; Case-Control Studies; Coronary Restenosis; Female; Graft Occlusion, Vascular; Humans; Lipoprotein(a); Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Middle Aged; Percutaneous Coronary Intervention; Peroxidase; Phosphatidylcholine-Sterol O-Acyltransferase; Stents; Vascular Patency | 2015 |
Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned.
Topics: Absorbable Implants; Adult; Aged; Aged, 80 and over; Arginine; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Sulfonamides; Treatment Outcome | 2016 |
A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Humans; Male; Metals; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Protein Precursors; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome | 2010 |
E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levels.
Topics: Aged; Aged, 80 and over; Angioplasty; Angioplasty, Balloon; Arginine; Codon; Coronary Restenosis; E-Selectin; Female; Genotype; Homozygote; Humans; Inflammation; Ischemia; Linear Models; Male; Odds Ratio; Polymorphism, Genetic; Prognosis; Proportional Hazards Models; Serine; Time Factors | 2004 |
Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery.
Topics: Aged; Angina, Unstable; Antibodies; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Restenosis; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Heparin; Humans; Male; Myocardial Revascularization; Partial Thromboplastin Time; Pipecolic Acids; Reoperation; Stents; Sulfonamides; Treatment Failure | 2004 |
Effect of short-term administration of high dose L-arginine on restenosis after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Coronary Restenosis; Cyclic GMP; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide | 2004 |
The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Membrane Glycoproteins; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Predictive Value of Tests; Receptors, Fibroblast Growth Factor; Serine; Sialoglycoproteins; Treatment Outcome | 2002 |